{"id":"activated-allogeneic-white-blood-cells","safety":{"commonSideEffects":[{"rate":"null","effect":"Injection site reactions"},{"rate":"null","effect":"Fever"},{"rate":"null","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is achieved through the activation of white blood cells, which are then administered to the patient to enhance their immune response. The exact mechanism of action may vary depending on the specific disease being targeted.","oneSentence":"Activated allogeneic white blood cells stimulate the immune system to fight infections and diseases.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:20:37.363Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of diabetic foot ulcers"}]},"trialDetails":[{"nctId":"NCT03910452","phase":"EARLY_PHASE1","title":"Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-10-28","conditions":"Chronic Granulomatous Disease","enrollment":4},{"nctId":"NCT01045460","phase":"PHASE2","title":"Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2010-01-15","conditions":"Multiple Myeloma","enrollment":36},{"nctId":"NCT01113307","phase":"","title":"The Use of CureXcellTM in a Community Setting for the Treatment of Hard to Heal Wounds","status":"COMPLETED","sponsor":"Macrocure Ltd.","startDate":"2010-05","conditions":"Wounds","enrollment":131}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["CureXcell"],"phase":"phase_2","status":"active","brandName":"Activated allogeneic white blood cells","genericName":"Activated allogeneic white blood cells","companyName":"Macrocure Ltd.","companyId":"macrocure-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"Activated allogeneic white blood cells stimulate the immune system to fight infections and diseases. Used for Treatment of diabetic foot ulcers.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}